Edit |   |
---|---|
Antigenic Specificity | CD192, Human (Plozalizumab biosimilar) |
Clone | Plozalizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, IF, IP, FCM, Inhib |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD192 Recombinant Antibody. Plozalizumab (INN, hu1D9) is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency. This drug was developed by Takeda Pharmaceuticals International Co. |
Immunogen | n/a |
Other Names | Anti-CD192 Recombinant Antibody, Research Grade Plozalizumab, Anti-Human CD192 Recombinant Antibody, MLN-1202, anti-CCR2, hu1D9, Antibody Drug Analogues, Monoclonal Antibody, YR1384, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1610761-46-0 |
Catalog # | YR1384 |
Price | please inquire |
Order / More Info | CD192, Human (Plozalizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |